Nukkleus Valuation
| NUKK Stock | USD 15.70 1.62 11.51% |
At this time, the firm appears to be overvalued. Nukkleus secures a last-minute Real Value of $15.07 per share. The latest price of the firm is $15.7. Our model forecasts the value of Nukkleus from analyzing the firm fundamentals such as Current Valuation of 70.83 M, return on equity of -7.42, and Profit Margin of (1.44) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nukkleus' price fluctuation is out of control at this time. Calculation of the real value of Nukkleus is based on 3 months time horizon. Increasing Nukkleus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Nukkleus' intrinsic value may or may not be the same as its current market price of 15.70, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.7 | Real 15.07 | Hype 14.8 |
The intrinsic value of Nukkleus' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nukkleus' stock price.
Estimating the potential upside or downside of Nukkleus helps investors to forecast how Nukkleus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nukkleus more accurately as focusing exclusively on Nukkleus' fundamentals will not take into account other important factors: Nukkleus Total Value Analysis
Nukkleus is now forecasted to have valuation of 70.83 M with market capitalization of 75.21 M, debt of 4 M, and cash on hands of 23.14 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nukkleus fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
70.83 M | 75.21 M | 4 M | 23.14 K |
Nukkleus Investor Information
About 52.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nukkleus recorded a loss per share of 39.44. The entity had not issued any dividends in recent years. The firm had 1:8 split on the 24th of October 2024. Based on the key indicators related to Nukkleus' liquidity, profitability, solvency, and operating efficiency, Nukkleus is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in April.Nukkleus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nukkleus has an asset utilization ratio of 600.35 percent. This suggests that the Company is making $6.0 for each dollar of assets. An increasing asset utilization means that Nukkleus is more efficient with each dollar of assets it utilizes for everyday operations.Nukkleus Ownership Allocation
The market capitalization of Nukkleus is $75.21 Million. Nukkleus holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Nukkleus Profitability Analysis
The company reported the previous year's revenue of 5.91 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 998.52 K.About Nukkleus Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Nukkleus. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nukkleus based exclusively on its fundamental and basic technical indicators. By analyzing Nukkleus's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Nukkleus's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nukkleus. We calculate exposure to Nukkleus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nukkleus's related companies.Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd. Nukkleus operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 12 people.
Nukkleus Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nukkleus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 14.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.